Regulation of the circulation of veterinary medicinal substances in the Eurasian Economic Union based on uniform principles: transition challenges

This is the authors' abstract. We don't add key points for this paper.

The article provides a comprehensive analysis of the legal regulation of veterinary medicinal substances circulation within the Eurasian Economic Union (EAEU) in the context of the transition from mutual recognition to uniform procedures. The relevance of the study is detremined by the uneven readiness of the EAEU member states to implement supranational norms, the need to identify potential barriers to the formation of a common market, and the development of measures to overcome them. Based on an analysis of the regulatory framework (the Treaty on the EAEU, the EAEU Rules, and decisions of the Eurasian Economic Commission), the study establishes that the key challenge is the lack of sufficient practical experience in applying the new procedures and of reliable data on the actual readiness of regulatory authorities and businesses to comply with the new requirements. Additional obstacles include the absence of approved fee schedules and clearly defined powers of the authorized bodies. The authors propose completing the harmonization of national legal acts within the extended transitional period (until 2030), synchronizing the timelines for bringing registration dossiers into compliance with the EAEU Pharmacopoeia, and strengthening information exchange and the harmonizing inspection approaches among member states. The implementation of these measures, in the authors' opinion, will remove institutional barriers, ensure predictability of the regulatory environment, and create conditions for the sustainable development of veterinary medicinal products manufacturing throughout the EAEU.